Blebbistatin

CAS No. 674289-55-5

Blebbistatin ( (±)-Blebbistatin )

Catalog No. M24685 CAS No. 674289-55-5

Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 63 In Stock
10MG 120 In Stock
25MG 203 In Stock
50MG 357 In Stock
100MG 538 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Blebbistatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
  • Description
    Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing. Furthermore it preserves cell junctional integrity and barrier function.
  • Synonyms
    (±)-Blebbistatin
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    non-muscle myosin II ATPases
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    674289-55-5
  • Formula Weight
    292.3
  • Molecular Formula
    C18H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 23 mg/mL (78.67 mM; Need ultrasonic)
  • SMILES
    Cc(cc1)cc(C(C2(CC3)O)=O)c1N=C2N3c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ho WT, et al. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. J Mol Med (Berl). 2019 Sep;97(9):1345-1357.
molnova catalog
related products
  • BRITE338733

    BRITE 338733 is a novel inhibitor of ATPase. BRITE 338733 inhibits the expression of RecA in bacteria with IC50 value of 4.7 μM for the bacterial infections treatment.

  • Liriodendrin

    Liriodendrin regulates lung inflammation, the phosphorylation of the NF-kB (p65) and expression of vascular endothelial growth factor (VEGF).

  • Blebbistatin

    Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.